Leading Stem Cell Researcher Aims to Collaborate with NASOM for Enhanced Autism Care in Malaysia

PETALING JAYA, Malaysia (5 Aug 2024) – In a groundbreaking visit that holds promise for the future of autism treatment in Malaysia, renowned stem cell researcher Prof. Dr. Mike Chan met with the Chairman of the National Autism Society of Malaysia (NASOM) Julian Wong to discuss innovative approaches for supporting children with neurodevelopmental disorders.

With 40 years of bioregenerative experience and the author of 60 influential books and 130 research papers, including one focused on the potential of brain-and-organ specific precursor stem cells therapy, Prof. Chan expressed a profound enthusiasm for his first engagement with Nasom.

“I am truly excited to be here today at NASOM” Prof. Chan said, addressing the meeting on Monday afternoon at their headquarters in Petaling Jaya.

“Understanding brain functions is paramount in developing effective treatments. We have an opportunity to harness targeted brain-specific stem cells that can potentially revolutionize autism therapy.”

Prof. Mike Chan, who draws from his personal experiences as a parent of an autistic child, emphasized the challenges faced by families navigating this complex landscape.

“As a parent, I have walked this path. The hurdles can be daunting, but through collaboration and research, we can turn these challenges into opportunities for our children,” he noted.

Meanwhile NASOM, which has been a pillar of support for nearly 40 years, is dedicated to raising awareness about autism while fostering acceptance in the community. Prof. Mike Chan highlighted the unique gifts of autistic individuals, referencing historical figures like Isaac Newton and Beethoven to illustrate that greatness can emerge from neurodiversity.

“Our mission is to change perceptions and demonstrate that autistic individuals possess extraordinary talents,” said Wong. 

“However, we face significant challenges, particularly in terms of public awareness and integration into society. Prof. Chan’s insights into stem cell therapy provide us with hope for not just treatment, but for creating a more inclusive environment.”

During the discussion, both parties underscored the need for sustained funding and charitable contributions to advance their goals.

Prof. Chan voiced a strong commitment to collaborating with NASOM to secure the necessary resources for research and development in this vital field.

“The more we can engage with organizations like NASOM, the better equipped we will be to provide effective solutions and support,” Prof. Chan stated. “Together, we can make strides toward not only treating autism but embracing it as a vital part of our society.”

The meeting concluded with a shared vision for the future, as both Prof. Chan and Julian Wong called for long-term partnerships to tackle the stigma surrounding autism in Malaysia. They agreed that by improving societal attitudes and promoting understanding, they can ultimately reduce government costs associated with lack of integration.

As Malaysia continues to navigate the complexities of neurodevelopmental disorders, the collaboration between cutting-edge research and grassroots advocacy promises to be a beacon of hope for many families.

The commitment from both Prof. Chan and NASOM heralds a new chapter in the ongoing journey toward awareness, acceptance, and innovation in autism treatment.